Hirofumi Hirakawa, MD, PhD

Department of Neuropsychiatry, Oita University Faculty of Medicine, Yufu-city, Oita, Japan

PCC
Clozapine-Induced Corrected QT-Interval Prolongation and Relationship With Serum Clozapine Concentration
Case Report

December 18, 2025

The author presents a case of clozapine-induced QTc prolongation and discusses its relationship with serum clozapine concentration
PCC
Treatment Decision-Making Capacity With the MacCAT-T in Schizophrenia
Brief Report

June 1, 2023

This report is a narrative review of the studies on schizophrenia that evaluated both decision-making capacity for treatment with the MacCAT-T and severity of symptoms using a clinical rating...
JCP
Letter to the Editor

June 16, 2020

This letter comments on the article "Optimizing Treatment Choices to Improve Adherence and Outcomes in Schizophrenia" by Kane and Correll.
,
PCC
Letter to the Editor

September 7, 2017

Negative symptoms cause serious personal, social, and occupational functioning disability in schizophrenia patients. To date, the effect of bright light therapy on negative symptoms has been rarely studied, and...
, , , et al
PCC
Letter to the Editor

October 15, 2015

, , , et al

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe